Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Accelagen Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (63)
Prescription medicine registration (26)
Cancellation by sponsor (5)
Prescription medicine evaluation (3)
COVID-19 test kit (1)

Date

2025 (22)
2024 (4)
2023 (1)
2022 (27)
2021 (17)
2020 (16)
2019 (4)
2016 (3)
2001 (4)

Search

Sponsor content

98 result(s) found, displaying 71 to 80

TALMINEX oseltamivir (as phosphate) 75 mg capsule blister pack (312887)

25 February 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TALMINEX oseltamivir (as phosphate) 75 mg capsule blister pack.
TALMINEX oseltamivir (as phosphate) 30 mg capsule blister pack (312888)

25 February 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TALMINEX oseltamivir (as phosphate) 30 mg capsule blister pack.
MSN-SOLIFENACIN solifenacin succinate 10 mg film-coated tablet blister pack (314024)

10 January 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MSN-SOLIFENACIN solifenacin succinate 10 mg film-coated tablet blister pack.
MSN-SOLIFENACIN solifenacin succinate 5 mg film-coated tablet blister pack (314023)

10 January 2020

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MSN-SOLIFENACIN solifenacin succinate 5 mg film-coated tablet blister pack.
AZACITIDINE MSN; AZACITIDINE SANDOZ (Accelagen Pty Ltd)

20 October 2021

Prescription medicine registration

Active ingredients: azacitidine.
Accelagen Pty Ltd - Severe acute respiratory syndrome-associated coronavirus IVDs Cancelled under Section 41GL(d) of the Act

30 June 2021

Cancellation by sponsor

Requested by Accelagen Pty Ltd
MSN-BORTEZOMIB bortezomib 3.5 mg powder for injection vial (306550)

14 May 2019

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MSN-BORTEZOMIB bortezomib 3.5 mg powder for injection vial.
RESOLUTE 2.0

3 June 2021

COVID-19 test kit

Nucleic Acid Test - Intended for use: Laboratory.
Plunkett Consulting Pty Ltd - General/multiple surgical laser system beam guide Cancelled under Section 41GL(d) of the Act

19 April 2021

Cancellation by sponsor

Requested by Accelagen Pty Ltd
DIMETHYL FUMARATE MSN (Accelagen Pty Ltd)

9 April 2021

Prescription medicine registration

Active ingredients: dimethyl fumarate.

Pages

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Current page 8
Page 9
Page 10
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.